HIV viral load markers in clinical practice

被引：445
作者：
Saag, MS
Holodniy, M
Kuritzkes, DR
OBrien, WA
Coombs, R
Poscher, ME
Jacobsen, DM
Shaw, GM
Richman, DD
Volberding, PA
机构：
[1] STANFORD UNIV,STANFORD,CA 94305
[2] PALO ALTO VET AFFAIRS HLTH CARE SYST,PALO ALTO,CA
[3] UNIV COLORADO,HLTH SCI CTR,BOULDER,CO 80309
[4] UNIV CALIF LOS ANGELES,SCH MED,LOS ANGELES,CA 90024
[5] W LOS ANGELES VET AFFAIRS MED CTR,LOS ANGELES,CA
[6] UNIV WASHINGTON,SEATTLE,WA 98195
[7] UNIV CALIF SAN FRANCISCO,SCH MED,SAN FRANCISCO,CA 94143
[8] UNIV CALIF SAN DIEGO,LA JOLLA,CA 92093
[9] SAN DIEGO VET AFFAIRS MED CTR,SAN DIEGO,CA
来源：
NATURE MEDICINE | 1996年 / 2卷 / 06期
关键词：
D O I：
10.1038/nm0696-625
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
[No abstract available]
引用
收藏
页码：625 / 629
页数：5
相关论文
共 33 条
[1]  
Brambilla D., 1996, P155
[2]   CLINICAL-EVALUATION OF BRANCHED DNA SIGNAL AMPLIFICATION FOR QUANTIFYING HIV TYPE-1 IN HUMAN PLASMA [J].
CAO, YZ ;
HO, DD ;
TODD, J ;
KOKKA, R ;
URDEA, M ;
LIFSON, JD ;
PIATAK, M ;
CHEN, S ;
HAHN, BH ;
SAAG, MS ;
SHAW, GM .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 (03) :353-361
[3]   HIGH TITERS OF CYTOPATHIC VIRUS IN PLASMA OF PATIENTS WITH SYMPTOMATIC PRIMARY HIV-1 INFECTION [J].
CLARK, SJ ;
SAAG, MS ;
DECKER, WD ;
CAMPBELLHILL, S ;
ROBERSON, JL ;
VELDKAMP, PJ ;
KAPPES, JC ;
HAHN, BH ;
SHAW, GM .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (14) :954-960
[4]   PLASMA VIREMIA IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTION [J].
COOMBS, RW ;
COLLIER, AC ;
ALLAIN, JP ;
NIKORA, B ;
LEUTHER, M ;
GJERSET, GF ;
COREY, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (24) :1626-1631
[5]  
COOMBS RW, IN PRESS J INFECT DI
[6]   A SHORT-TERM STUDY OF THE SAFETY, PHARMACOKINETICS, AND EFFICACY OF RITONAVIR, AN INHIBITOR OF HIV-1 PROTEASE [J].
DANNER, SA ;
CARR, A ;
LEONARD, JM ;
LEHMAN, LM ;
GUDIOL, F ;
GONZALES, J ;
RAVENTOS, A ;
RUBIO, R ;
BOUZA, E ;
PINTADO, V ;
AGUADO, AG ;
DELOMAS, JG ;
DELGADO, R ;
BORLEFFS, JCC ;
HSU, A ;
VALDES, JM ;
BOUCHER, CAB ;
COOPER, DA ;
GIMENO, C ;
CLOTET, B ;
TOR, J ;
FERRER, E ;
MARTINEZ, PL ;
MORENO, S ;
ZANCADA, G ;
ALCAMI, J ;
NORIEGA, AR ;
PULIDO, F ;
GLASSMAN, HN .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (23) :1528-1533
[7]   TREATMENT WITH LAMIVUDINE, ZIDOVUDINE, OR BOTH IN HIV-POSITIVE PATIENTS WITH 200 TO 500 CD4+ CELLS PER CUBIC MILLIMETER [J].
ERON, JJ ;
BENOIT, SL ;
JEMSEK, J ;
MACARTHUR, RD ;
SANTANA, J ;
QUINN, JB ;
KURITZKES, DR ;
FALLON, MA ;
RUBIN, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (25) :1662-1669
[8]  
Hammer S. M., 1996, P175
[9]   A PILOT-STUDY TO EVALUATE THE DEVELOPMENT OF RESISTANCE TO NEVIRAPINE IN ASYMPTOMATIC HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS WITH CD4 CELL COUNTS OF GREATER-THAN-500/MM(3) - AIDS CLINICAL-TRIALS GROUP PROTOCOL-208 [J].
HAVLIR, D ;
MCLAUGHLIN, MM ;
RICHMAN, DD .
JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (05) :1379-1383
[10]  
Heath-Chiozzi Margo, 1996, P162
1234